Synergistic Treatment System for Surgery-Induced Cachexia
Legal Citation
Summary of the Inventive Concept
A comprehensive system integrating AI, IoT, blockchain, and novel biomaterials to prevent and treat surgery-induced cachexia, enhancing patient outcomes and quality of life.
Background and Problem Solved
The original patent addressed the treatment of surgery-induced cachexia using specialized immunonutrition supplements. However, it did not account for the complexity of individual patient responses, limited data tracking, and the potential for more effective treatment combinations. The new inventive concept overcomes these limitations by incorporating cutting-edge technologies to create a personalized, data-driven, and synergistic treatment system.
Detailed Description of the Inventive Concept
The system comprises a wearable device for monitoring vital signs, a blockchain-based health record for secure data tracking, and an AI algorithm generating personalized treatment plans. The system administers a specialized immunonutrition supplement, which can be combined with novel biomaterial implants for enhanced wound healing. IoT-enabled sensors monitor and adjust the supplement's delivery in real-time based on the patient's physiological response. A machine learning model predicts patient outcomes, and a user interface provides healthcare providers with data-driven treatment recommendations.
Novelty and Inventive Step
The integration of AI, IoT, blockchain, and novel biomaterials with the original patented concept creates a new, non-obvious synergistic treatment system. The AI-driven analytics and IoT-enabled real-time monitoring introduce a level of personalization and adaptability not present in the original patent.
Alternative Embodiments and Variations
Alternative embodiments could include the use of different AI algorithms, varying IoT sensor configurations, or the incorporation of additional biomaterials. Variations could involve integrating the system with existing electronic health records or using different types of wearable devices.
Potential Commercial Applications and Market
The synergistic treatment system has significant commercial potential in the healthcare industry, particularly in the fields of surgical oncology, wound care, and personalized medicine. Target markets include hospitals, clinics, and healthcare providers seeking to improve patient outcomes and reduce treatment costs.
Section 103 Obviousness Analysis (PHOSITA)
Field of Art
Medical nutrition, oncology, and digital health technologies with a focus on patient treatment systems for surgical interventions and metabolic disorders
Person of Ordinary Skill (PHOSITA) Profile
A professional with expertise in biomedical engineering, nutrition science, and digital health technologies, possessing advanced degrees and experience in developing patient monitoring and treatment systems
Obviousness Rationale
A PHOSITA would recognize that integrating digital monitoring technologies with established nutritional interventions represents a predictable extension of existing medical treatment methodologies. The combination of AI-driven personalization, IoT sensor monitoring, and blockchain data tracking with the source patent's specialized immunonutrition supplement creates a logical progression of treatment optimization strategies. The technical variations represent incremental improvements that would be apparent to a skilled practitioner seeking to enhance patient care through technological integration.
Obvious Combinations & Variations
Original Patent Information
| Patent Number | US 11,857,525 |
|---|---|
| Title | Treatment or prevention of surgery-induced cachexia and/or expression of myeloid-derived suppressor cells and pro-inflammatory cytokines |
| Assignee(s) | SOCIÉTÉ DES PRODUITS NESTLÉ S.A. |